BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26574188)

  • 1. External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.
    Zhao CY; Jiao Z; Mao JJ; Qiu XY
    Br J Clin Pharmacol; 2016 May; 81(5):891-907. PubMed ID: 26574188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients.
    Cai X; Li R; Sheng C; Tao Y; Zhang Q; Zhang X; Li J; Shen C; Qiu X; Wang Z; Jiao Z
    Eur J Pharm Sci; 2020 Mar; 145():105237. PubMed ID: 32001346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.
    Zhang HX; Sheng CC; Liu LS; Luo B; Fu Q; Zhao Q; Li J; Liu YF; Deng RH; Jiao Z; Wang CX
    Br J Clin Pharmacol; 2019 Apr; 85(4):746-761. PubMed ID: 30597603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.
    Mao JJ; Jiao Z; Yun HY; Zhao CY; Chen HC; Qiu XY; Zhong MK
    Br J Clin Pharmacol; 2018 Jan; 84(1):153-171. PubMed ID: 28891596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes.
    Hu C; Yin WJ; Li DY; Ding JJ; Zhou LY; Wang JL; Ma RR; Liu K; Zhou G; Zuo XC
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1437-1447. PubMed ID: 30019212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
    Brooks E; Tett SE; Isbel NM; Staatz CE
    Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External evaluation of published population pharmacokinetic models of polymyxin B.
    Li YQ; Chen KF; Ding JJ; Tan HY; Yang N; Lin YQ; Wu CF; Xie YL; Yang GP; Liu JJ; Pei Q
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1909-1917. PubMed ID: 34342716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
    Benkali K; Prémaud A; Picard N; Rérolle JP; Toupance O; Hoizey G; Turcant A; Villemain F; Le Meur Y; Marquet P; Rousseau A
    Clin Pharmacokinet; 2009; 48(12):805-16. PubMed ID: 19902988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
    Prytuła AA; Cransberg K; Bouts AH; van Schaik RH; de Jong H; de Wildt SN; Mathôt RA
    Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.
    Li ZR; Li RD; Niu WJ; Zheng XY; Wang ZX; Zhong MK; Qiu XY
    J Clin Pharmacol; 2023 Mar; 63(3):314-325. PubMed ID: 36097320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach.
    Andreu F; Colom H; Elens L; van Gelder T; van Schaik RHN; Hesselink DA; Bestard O; Torras J; Cruzado JM; Grinyó JM; Lloberas N
    Clin Pharmacokinet; 2017 Aug; 56(8):963-975. PubMed ID: 28050888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
    Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
    Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
    Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
    J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling.
    Størset E; Holford N; Hennig S; Bergmann TK; Bergan S; Bremer S; Åsberg A; Midtvedt K; Staatz CE
    Br J Clin Pharmacol; 2014 Sep; 78(3):509-23. PubMed ID: 25279405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
    Han N; Ha S; Yun HY; Kim MG; Min SI; Ha J; Lee JI; Oh JM; Kim IW
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):400-6. PubMed ID: 24238261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
    Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
    Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review.
    Kirubakaran R; Stocker SL; Hennig S; Day RO; Carland JE
    Clin Pharmacokinet; 2020 Nov; 59(11):1357-1392. PubMed ID: 32783100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients.
    Kirubakaran R; Hennig S; Maslen B; Day RO; Carland JE; Stocker SL
    Br J Clin Pharmacol; 2022 Feb; 88(4):1751-1772. PubMed ID: 34558092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: A systematic review.
    Khamlek K; Komenkul V; Sriboonruang T; Wattanavijitkul T
    Br J Clin Pharmacol; 2024 Feb; 90(2):406-426. PubMed ID: 37714740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients.
    Kirubakaran R; Uster DW; Hennig S; Carland JE; Day RO; Wicha SG; Stocker SL
    Br J Clin Pharmacol; 2023 Mar; 89(3):1162-1175. PubMed ID: 36239542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.